Leveraging AI for Better Outcomes Across Drug Development - with Patricio La Rosa of Bayer
Release Date: 05/13/2025
The AI in Business Podcast
Today’s guest is Alain-Sam Cohen, Head of Product at InstaDeep—an AI firm using reinforcement learning and other advanced techniques to solve complex design and optimization problems across industries. It may not make headlines like generative AI, but for manufacturers and engineers, PCB design remains one of the most time-intensive steps in building physical systems. From strict physical constraints to millions of potential component arrangements, even expert teams face persistent bottlenecks. Alain-Sam breaks down how InstaDeep’s AI-driven approach is changing that reality—using...
info_outlineThe AI in Business Podcast
Today’s guest is Damion Nero, Head of Data Science at Takeda Pharmaceuticals. With over 15 years of experience applying AI, machine learning, and real-world data to drug development and precision medicine, Damion joins Emerj Managing Editor Matthew DeMello to explore the evolving role of AI in drug development and supply chain management. He breaks down how AI is currently streamlining administrative and regulatory tasks, improving efficiency across clinical trials, and saving valuable time for healthcare professionals. Damion also discusses why broader, transformative supply chain...
info_outlineThe AI in Business Podcast
With customer expectations at an all-time high, even one broken interaction can result in permanent brand damage. In this episode of ‘AI in Business,’ Cognigy Chief Marketing Officer Alan Ranger joins Emerj Editorial Director Matthew DeMello to explore how conversational, generative, and agentic AI are reshaping contact center strategy across telecom, retail, and financial services. Cognigy is a leading provider of AI-powered customer service solutions, offering an advanced platform that enables businesses to deliver instant, personalized, and multilingual support across various channels....
info_outlineThe AI in Business Podcast
Today’s guest is Xiong Liu, Director of Data Science and AI at Novartis. Xiong returns to the platform in a special episode brought to you by Medable to explore the evolving role of AI in modernizing clinical trials. Their conversation covers how life sciences teams are leveraging AI to streamline data workflows, accelerate study readiness, and maintain regulatory compliance in both decentralized and traditional models. Throughout the episode, Xiong shares insights into the growing importance of integrating structured and unstructured data across trial systems — from clinical notes to...
info_outlineThe AI in Business Podcast
Today’s guest is Jiaxi Zhu, Head of Analytics & Insights at Google. Jiaxi joins Emerj Editorial Director Matthew DeMello to explore how enterprises can strengthen data security and governance as customer analytics increasingly relies on both structured and unstructured data. As organizations expand their use of sources like call transcripts, social media posts, and third-party platforms, traditional data protection models are no longer sufficient. Jiaxi explains how modernizing data governance with comprehensive data dictionaries and metadata management is essential for understanding...
info_outlineThe AI in Business Podcast
Today’s guest is Chris Tapley, Vice President and Head of Financial Services Consulting for North America at EPAM Systems. EPAM is a global digital engineering company that provides software development and consulting services across industries, including financial services, healthcare, and media. With deep experience guiding AI adoption in regulated industries, Chris joins Emerj Editorial Director Matthew DeMello on the show today to unpack the foundational challenges facing financial institutions as they move from experimentation to production. He explores the technical and organizational...
info_outlineThe AI in Business Podcast
Today’s guest is Shreyas Becker, Head of AI & Data Products, Manufacturing & Supply at Sanofi. Shreyas joins Emerj Managing Editor Matthew DeMello to discuss the practical application of AI in life sciences, focusing on tools that are already improving supply chain resilience and manufacturing efficiency. He explains how AI helps navigate geopolitical disruptions, optimize production workflows, and ensure the reliable delivery of critical medications. The conversation also covers the evolution of AI systems developed during the pandemic and their role in shaping future innovations....
info_outlineThe AI in Business Podcast
Today’s guest is Daniel Ferrante, AI Leader in R&D and Data Strategy at Deloitte. Daniel joins Emerj CEO and Head of Research Daniel Faggella on today’s show to delve into the intersection of AI, data strategy, and research and development across industries such as agriculture, life sciences, and materials science. Ferrante breaks down the core challenges organizations face in harnessing data to unlock AI’s potential and drive efficiencies in R&D processes. Ferrante also emphasizes the importance of contextualizing data through a multimodal framework — Deloitte’s Atlas — to...
info_outlineThe AI in Business Podcast
Today’s guest is Greg Cucino, Managing Director at RoundTable Strategy Advisors. RoundTable is a leading firm specializing in CFO and NetSuite services that help businesses boost financial management and operational efficiency. Greg joins Emerj Editorial Director Matthew DeMello on the podcast to share his perspective on how AI is redefining the CFO role. As AI automates manual finance and accounting workflows, executives are shifting focus from historical data to forward-looking strategy. Greg also explores emerging AI technologies, including agentic AI, and how they’re set to transform...
info_outlineThe AI in Business Podcast
Today’s guest is Sidharth Ojha, Head of Process Optimization in Data and AI at AXA XL, a global commercial insurance and reinsurance company and subsidiary of AXA. Sidharth joins Emerj Managing Editor Matthew DeMello to discuss how AI is being applied across commercial insurance workflows with real, measurable impact. He explains how machine learning is enhancing underwriting efficiency, portfolio decision-making, and risk assessment. The conversation also covers key enablers for scaling AI, including data quality, governance, and change management. For insurance professionals and data...
info_outlineToday’s guest is Patricio La Rosa, Head of End-to-End Decision Science at Seed Production Innovation in Bayer Crop Science. With over 20 years of experience developing AI and data science solutions across healthcare and agriculture, Patricio joins Emerj Managing Editor Matthew DeMello to explore how machine learning can drive better outcomes across the drug development lifecycle, from research design to clinical deployment.
Patricio discusses how AI is optimizing early trial planning, improving participant engagement, and supporting ethical, human-centered decisions at scale. Drawing lessons from both agriculture and life sciences, he emphasizes the importance of connecting technical models with real-world workflows.
The conversation also delves into key barriers to AI adoption in clinical settings, including behavioral friction, model transparency, and challenges in orchestrating decision-making across global teams. Patricio offers a grounded perspective on what it takes to move from experimentation to enterprise impact in AI-driven R&D. Want to share your AI adoption story with executive peers? Click emerj.com/expert2 for more information and to be a potential future guest on Emerj’s flagship ‘AI in Business’ podcast!